Compare LITS & AVAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LITS | AVAT |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | 4 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.7M | 21.3M |
| IPO Year | N/A | N/A |
| Metric | LITS | AVAT |
|---|---|---|
| Price | $0.99 | $0.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 175.7K | ★ 473.1K |
| Earning Date | 05-19-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.69 | $0.31 |
| 52 Week High | $3.03 | $0.94 |
| Indicator | LITS | AVAT |
|---|---|---|
| Relative Strength Index (RSI) | 51.62 | 21.21 |
| Support Level | $0.93 | N/A |
| Resistance Level | $0.99 | $0.58 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 39.83 | 3.33 |
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
Avalanche Treasury Corp is a digital asset treasury company.